Theracues Innovations Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 17-07-2024
- Paid Up Capital ₹ 0.78 M
as on 17-07-2024
- Company Age 8 Year, 26 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 5.00 M
as on 17-07-2024
- Revenue 93.58%
(FY 2022)
- Profit 226.89%
(FY 2022)
- Ebitda 253.84%
(FY 2022)
- Net Worth 728.27%
(FY 2022)
- Total Assets 167.35%
(FY 2022)
About Theracues Innovations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.78 M.
The company currently has active open charges totaling ₹5.00 M.
Anurag Varshney, Suma Nagaraju, and Gopalakrishna Ramaswamy serve as directors at the Company.
- CIN/LLPIN
U74999KA2016PTC098059
- Company No.
098059
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Nov 2016
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Theracues Innovations Private Limited offer?
Theracues Innovations Private Limited offers a wide range of products and services, including Pharma & Bioanalytical Services, Pharmaceutical Services, Software Development & IT Consultant, Software Development Services.
Who are the key members and board of directors at Theracues Innovations?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gopalakrishna Ramaswamy  | Director | 25-Nov-2016 | Current |
| Anurag Varshney | Director | 30-May-2017 | Current |
| Suma Nagaraju | Director | 25-Nov-2016 | Current |
Financial Performance of Theracues Innovations.
Theracues Innovations Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 93.58% increase. The company also saw a substantial improvement in profitability, with a 226.89% increase in profit. The company's net worth Soared by an impressive increase of 728.27%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Theracues Innovations?
In 2021, Theracues Innovations had a promoter holding of 90.83% and a public holding of 9.17%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Oct 2022 | ₹5.00 M | Open |
How Many Employees Work at Theracues Innovations?
Unlock and access historical data on people associated with Theracues Innovations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Theracues Innovations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Theracues Innovations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
